SCIENCE OVER STIGMA, NASTAD

September 13, 2017   Dear Colleagues:   In response to the introduction of effective, short-course, curative hepatitis C (HCV) treatments, shifting HCV trends nationwide, and calls for universal access to treatment. NASTAD has recently released Science over Stigma: The Public Health Case Against HCV Treatment Sobriety Restrictions which explores the impact of private and public insurance sobriety […]

Share Button